Project
Inflammatory response time course, HUVEC (Wada et al., 2009)
Navigation
Downloads
Results for GTF2I
Z-value: 1.25
Motif logo
Transcription factors associated with GTF2I
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
GTF2I
|
ENSG00000077809.8 | general transcription factor IIi |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| GTF2I | hg19_v2_chr7_+_74072011_74072119 | 0.79 | 2.7e-06 | Click! |
Activity profile of GTF2I motif
Sorted Z-values of GTF2I motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr4_-_16900242 | 10.56 |
ENST00000502640.1
ENST00000506732.1 |
LDB2
|
LIM domain binding 2 |
| chr4_-_16900217 | 10.01 |
ENST00000441778.2
|
LDB2
|
LIM domain binding 2 |
| chr4_-_16900410 | 9.25 |
ENST00000304523.5
|
LDB2
|
LIM domain binding 2 |
| chr4_-_16900184 | 8.52 |
ENST00000515064.1
|
LDB2
|
LIM domain binding 2 |
| chr5_-_81046841 | 5.16 |
ENST00000509013.2
ENST00000505980.1 ENST00000509053.1 |
SSBP2
|
single-stranded DNA binding protein 2 |
| chr14_-_54423529 | 5.11 |
ENST00000245451.4
ENST00000559087.1 |
BMP4
|
bone morphogenetic protein 4 |
| chr11_+_125034586 | 4.86 |
ENST00000298282.9
|
PKNOX2
|
PBX/knotted 1 homeobox 2 |
| chr7_+_30951461 | 4.09 |
ENST00000311813.4
|
AQP1
|
aquaporin 1 (Colton blood group) |
| chr5_-_81046904 | 4.08 |
ENST00000515395.1
|
SSBP2
|
single-stranded DNA binding protein 2 |
| chr1_+_164528866 | 3.77 |
ENST00000420696.2
|
PBX1
|
pre-B-cell leukemia homeobox 1 |
| chr3_+_20081515 | 3.69 |
ENST00000263754.4
|
KAT2B
|
K(lysine) acetyltransferase 2B |
| chr4_+_41540160 | 3.16 |
ENST00000503057.1
ENST00000511496.1 |
LIMCH1
|
LIM and calponin homology domains 1 |
| chr5_+_139027877 | 3.14 |
ENST00000302517.3
|
CXXC5
|
CXXC finger protein 5 |
| chr2_-_152684977 | 3.07 |
ENST00000428992.2
ENST00000295087.8 |
ARL5A
|
ADP-ribosylation factor-like 5A |
| chr20_-_23030296 | 3.06 |
ENST00000377103.2
|
THBD
|
thrombomodulin |
| chr19_-_14201507 | 2.94 |
ENST00000533683.2
|
SAMD1
|
sterile alpha motif domain containing 1 |
| chr9_-_14314518 | 2.86 |
ENST00000397581.2
|
NFIB
|
nuclear factor I/B |
| chr9_-_14314566 | 2.84 |
ENST00000397579.2
|
NFIB
|
nuclear factor I/B |
| chr2_+_189156586 | 2.82 |
ENST00000409830.1
|
GULP1
|
GULP, engulfment adaptor PTB domain containing 1 |
| chr2_+_189156721 | 2.80 |
ENST00000409927.1
ENST00000409805.1 |
GULP1
|
GULP, engulfment adaptor PTB domain containing 1 |
| chr14_-_91526462 | 2.72 |
ENST00000536315.2
|
RPS6KA5
|
ribosomal protein S6 kinase, 90kDa, polypeptide 5 |
| chr4_+_30721968 | 2.70 |
ENST00000361762.2
|
PCDH7
|
protocadherin 7 |
| chr17_-_42276574 | 2.67 |
ENST00000589805.1
|
ATXN7L3
|
ataxin 7-like 3 |
| chr4_+_41361616 | 2.63 |
ENST00000513024.1
|
LIMCH1
|
LIM and calponin homology domains 1 |
| chr14_-_91526922 | 2.61 |
ENST00000418736.2
ENST00000261991.3 |
RPS6KA5
|
ribosomal protein S6 kinase, 90kDa, polypeptide 5 |
| chr6_-_16761678 | 2.56 |
ENST00000244769.4
ENST00000436367.1 |
ATXN1
|
ataxin 1 |
| chr9_-_14314066 | 2.56 |
ENST00000397575.3
|
NFIB
|
nuclear factor I/B |
| chr17_-_58469591 | 2.51 |
ENST00000589335.1
|
USP32
|
ubiquitin specific peptidase 32 |
| chrX_-_70474910 | 2.48 |
ENST00000373988.1
ENST00000373998.1 |
ZMYM3
|
zinc finger, MYM-type 3 |
| chr5_-_111092930 | 2.46 |
ENST00000257435.7
|
NREP
|
neuronal regeneration related protein |
| chr5_-_111093167 | 2.46 |
ENST00000446294.2
ENST00000419114.2 |
NREP
|
neuronal regeneration related protein |
| chr18_-_22932080 | 2.44 |
ENST00000584787.1
ENST00000361524.3 ENST00000538137.2 |
ZNF521
|
zinc finger protein 521 |
| chr7_-_132262060 | 2.43 |
ENST00000359827.3
|
PLXNA4
|
plexin A4 |
| chr3_-_168864427 | 2.35 |
ENST00000468789.1
|
MECOM
|
MDS1 and EVI1 complex locus |
| chr2_+_189156389 | 2.34 |
ENST00000409843.1
|
GULP1
|
GULP, engulfment adaptor PTB domain containing 1 |
| chr7_-_100425112 | 2.26 |
ENST00000358173.3
|
EPHB4
|
EPH receptor B4 |
| chr2_+_159313452 | 2.26 |
ENST00000389757.3
ENST00000389759.3 |
PKP4
|
plakophilin 4 |
| chr4_+_42399856 | 2.24 |
ENST00000319234.4
|
SHISA3
|
shisa family member 3 |
| chr1_+_61330931 | 2.19 |
ENST00000371191.1
|
NFIA
|
nuclear factor I/A |
| chr16_+_29819096 | 2.15 |
ENST00000568411.1
ENST00000563012.1 ENST00000562557.1 |
MAZ
|
MYC-associated zinc finger protein (purine-binding transcription factor) |
| chr8_-_93107443 | 2.13 |
ENST00000360348.2
ENST00000520428.1 ENST00000518992.1 ENST00000520556.1 ENST00000518317.1 ENST00000521319.1 ENST00000521375.1 ENST00000518449.1 |
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
| chr8_+_37654693 | 2.08 |
ENST00000412232.2
|
GPR124
|
G protein-coupled receptor 124 |
| chr16_+_29819372 | 2.07 |
ENST00000568544.1
ENST00000569978.1 |
MAZ
|
MYC-associated zinc finger protein (purine-binding transcription factor) |
| chr5_+_175298573 | 2.06 |
ENST00000512824.1
|
CPLX2
|
complexin 2 |
| chr2_-_75788038 | 2.03 |
ENST00000393913.3
ENST00000410113.1 |
EVA1A
|
eva-1 homolog A (C. elegans) |
| chr7_+_1094921 | 2.00 |
ENST00000397095.1
|
GPR146
|
G protein-coupled receptor 146 |
| chr5_-_111092873 | 1.95 |
ENST00000509025.1
ENST00000515855.1 |
NREP
|
neuronal regeneration related protein |
| chr1_+_109102652 | 1.95 |
ENST00000370035.3
ENST00000405454.1 |
FAM102B
|
family with sequence similarity 102, member B |
| chr1_-_92351769 | 1.95 |
ENST00000212355.4
|
TGFBR3
|
transforming growth factor, beta receptor III |
| chr17_-_49337392 | 1.93 |
ENST00000376381.2
ENST00000586178.1 |
MBTD1
|
mbt domain containing 1 |
| chr9_-_80646374 | 1.87 |
ENST00000286548.4
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide |
| chr11_-_118134997 | 1.81 |
ENST00000278937.2
|
MPZL2
|
myelin protein zero-like 2 |
| chr2_+_182756615 | 1.78 |
ENST00000431877.2
ENST00000320370.7 |
SSFA2
|
sperm specific antigen 2 |
| chrX_+_123095546 | 1.76 |
ENST00000371157.3
ENST00000371145.3 ENST00000371144.3 |
STAG2
|
stromal antigen 2 |
| chr16_+_29819446 | 1.76 |
ENST00000568282.1
|
MAZ
|
MYC-associated zinc finger protein (purine-binding transcription factor) |
| chr11_-_33891362 | 1.73 |
ENST00000395833.3
|
LMO2
|
LIM domain only 2 (rhombotin-like 1) |
| chr5_-_111093340 | 1.71 |
ENST00000508870.1
|
NREP
|
neuronal regeneration related protein |
| chr8_-_93115445 | 1.68 |
ENST00000523629.1
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
| chr17_-_42277203 | 1.67 |
ENST00000587097.1
|
ATXN7L3
|
ataxin 7-like 3 |
| chr8_-_38325219 | 1.67 |
ENST00000533668.1
ENST00000413133.2 ENST00000397108.4 ENST00000526742.1 ENST00000525001.1 ENST00000425967.3 ENST00000529552.1 ENST00000397113.2 |
FGFR1
|
fibroblast growth factor receptor 1 |
| chr6_-_32157947 | 1.65 |
ENST00000375050.4
|
PBX2
|
pre-B-cell leukemia homeobox 2 |
| chr8_-_93107827 | 1.64 |
ENST00000520724.1
ENST00000518844.1 |
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
| chr1_-_68698197 | 1.64 |
ENST00000370973.2
ENST00000370971.1 |
WLS
|
wntless Wnt ligand secretion mediator |
| chr14_+_61788429 | 1.64 |
ENST00000332981.5
|
PRKCH
|
protein kinase C, eta |
| chr2_+_219264466 | 1.63 |
ENST00000273062.2
|
CTDSP1
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 1 |
| chr17_+_60704762 | 1.62 |
ENST00000303375.5
|
MRC2
|
mannose receptor, C type 2 |
| chr4_-_102268484 | 1.62 |
ENST00000394853.4
|
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme |
| chr8_+_97506033 | 1.62 |
ENST00000518385.1
|
SDC2
|
syndecan 2 |
| chr2_-_191885686 | 1.61 |
ENST00000432058.1
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa |
| chr1_+_82266053 | 1.60 |
ENST00000370715.1
ENST00000370713.1 ENST00000319517.6 ENST00000370717.2 ENST00000394879.1 ENST00000271029.4 ENST00000335786.5 |
LPHN2
|
latrophilin 2 |
| chr12_-_50222187 | 1.60 |
ENST00000335999.6
|
NCKAP5L
|
NCK-associated protein 5-like |
| chr20_+_33759854 | 1.57 |
ENST00000216968.4
|
PROCR
|
protein C receptor, endothelial |
| chr2_+_182756915 | 1.56 |
ENST00000428267.2
|
SSFA2
|
sperm specific antigen 2 |
| chr8_-_22550815 | 1.53 |
ENST00000317216.2
|
EGR3
|
early growth response 3 |
| chr1_+_114522049 | 1.50 |
ENST00000369551.1
ENST00000320334.4 |
OLFML3
|
olfactomedin-like 3 |
| chr12_+_29302119 | 1.49 |
ENST00000536681.3
|
FAR2
|
fatty acyl CoA reductase 2 |
| chr5_+_139028510 | 1.46 |
ENST00000502336.1
ENST00000520967.1 ENST00000511048.1 |
CXXC5
|
CXXC finger protein 5 |
| chr6_-_31865452 | 1.45 |
ENST00000375530.4
ENST00000375537.4 |
EHMT2
|
euchromatic histone-lysine N-methyltransferase 2 |
| chr2_-_39664405 | 1.44 |
ENST00000341681.5
ENST00000263881.3 |
MAP4K3
|
mitogen-activated protein kinase kinase kinase kinase 3 |
| chr8_-_89339705 | 1.43 |
ENST00000286614.6
|
MMP16
|
matrix metallopeptidase 16 (membrane-inserted) |
| chr1_-_68698222 | 1.42 |
ENST00000370976.3
ENST00000354777.2 ENST00000262348.4 ENST00000540432.1 |
WLS
|
wntless Wnt ligand secretion mediator |
| chr20_+_34742650 | 1.41 |
ENST00000373945.1
ENST00000338074.2 |
EPB41L1
|
erythrocyte membrane protein band 4.1-like 1 |
| chr9_+_133971909 | 1.41 |
ENST00000247291.3
ENST00000372302.1 ENST00000372300.1 ENST00000372298.1 |
AIF1L
|
allograft inflammatory factor 1-like |
| chr17_+_38278530 | 1.40 |
ENST00000398532.4
|
MSL1
|
male-specific lethal 1 homolog (Drosophila) |
| chr12_-_96184533 | 1.39 |
ENST00000343702.4
ENST00000344911.4 |
NTN4
|
netrin 4 |
| chr19_-_31840438 | 1.38 |
ENST00000240587.4
|
TSHZ3
|
teashirt zinc finger homeobox 3 |
| chr4_+_55524085 | 1.36 |
ENST00000412167.2
ENST00000288135.5 |
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
| chrX_-_70473957 | 1.36 |
ENST00000373984.3
ENST00000314425.5 ENST00000373982.1 |
ZMYM3
|
zinc finger, MYM-type 3 |
| chr1_+_32538492 | 1.33 |
ENST00000336294.5
|
TMEM39B
|
transmembrane protein 39B |
| chr18_+_46065393 | 1.32 |
ENST00000256413.3
|
CTIF
|
CBP80/20-dependent translation initiation factor |
| chr1_-_9970227 | 1.32 |
ENST00000377263.1
|
CTNNBIP1
|
catenin, beta interacting protein 1 |
| chr1_+_153651078 | 1.30 |
ENST00000368680.3
|
NPR1
|
natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A) |
| chr2_-_240322643 | 1.30 |
ENST00000345617.3
|
HDAC4
|
histone deacetylase 4 |
| chr4_-_102268628 | 1.29 |
ENST00000323055.6
ENST00000512215.1 ENST00000394854.3 |
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme |
| chr1_-_208084729 | 1.29 |
ENST00000310833.7
ENST00000356522.4 |
CD34
|
CD34 molecule |
| chr12_-_118541743 | 1.29 |
ENST00000359236.5
|
VSIG10
|
V-set and immunoglobulin domain containing 10 |
| chr2_+_148778570 | 1.29 |
ENST00000407073.1
|
MBD5
|
methyl-CpG binding domain protein 5 |
| chrX_-_70474499 | 1.28 |
ENST00000353904.2
|
ZMYM3
|
zinc finger, MYM-type 3 |
| chr3_-_141747439 | 1.27 |
ENST00000467667.1
|
TFDP2
|
transcription factor Dp-2 (E2F dimerization partner 2) |
| chr8_-_93107696 | 1.26 |
ENST00000436581.2
ENST00000520583.1 ENST00000519061.1 |
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
| chr12_-_56615693 | 1.25 |
ENST00000394013.2
ENST00000345093.4 ENST00000551711.1 ENST00000552656.1 |
RNF41
|
ring finger protein 41 |
| chr4_-_114682936 | 1.25 |
ENST00000454265.2
ENST00000429180.1 ENST00000418639.2 ENST00000394526.2 ENST00000296402.5 |
CAMK2D
|
calcium/calmodulin-dependent protein kinase II delta |
| chr15_-_82338460 | 1.25 |
ENST00000558133.1
ENST00000329713.4 |
MEX3B
|
mex-3 RNA binding family member B |
| chr7_-_86688831 | 1.23 |
ENST00000423294.1
|
KIAA1324L
|
KIAA1324-like |
| chr17_+_73472575 | 1.22 |
ENST00000375248.5
|
KIAA0195
|
KIAA0195 |
| chr1_+_87380299 | 1.21 |
ENST00000370551.4
ENST00000370550.5 |
HS2ST1
|
heparan sulfate 2-O-sulfotransferase 1 |
| chr19_-_14201776 | 1.20 |
ENST00000269724.5
|
SAMD1
|
sterile alpha motif domain containing 1 |
| chr9_-_20622478 | 1.20 |
ENST00000355930.6
ENST00000380338.4 |
MLLT3
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 |
| chr19_+_45973120 | 1.19 |
ENST00000592811.1
ENST00000586615.1 |
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B |
| chr6_-_31864977 | 1.18 |
ENST00000395728.3
ENST00000375528.4 |
EHMT2
|
euchromatic histone-lysine N-methyltransferase 2 |
| chr7_-_21985656 | 1.17 |
ENST00000406877.3
|
CDCA7L
|
cell division cycle associated 7-like |
| chr7_-_21985489 | 1.17 |
ENST00000356195.5
ENST00000447180.1 ENST00000373934.4 ENST00000457951.1 |
CDCA7L
|
cell division cycle associated 7-like |
| chr16_+_29818857 | 1.17 |
ENST00000567444.1
|
MAZ
|
MYC-associated zinc finger protein (purine-binding transcription factor) |
| chr1_+_33005020 | 1.17 |
ENST00000373510.4
ENST00000316459.4 |
ZBTB8A
|
zinc finger and BTB domain containing 8A |
| chr2_-_191878681 | 1.17 |
ENST00000409465.1
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa |
| chr2_+_182756701 | 1.15 |
ENST00000409001.1
|
SSFA2
|
sperm specific antigen 2 |
| chr7_-_86688990 | 1.14 |
ENST00000450689.2
|
KIAA1324L
|
KIAA1324-like |
| chr11_-_2160180 | 1.14 |
ENST00000381406.4
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
| chr1_+_32538520 | 1.13 |
ENST00000438825.1
ENST00000456834.2 ENST00000373634.4 ENST00000427288.1 |
TMEM39B
|
transmembrane protein 39B |
| chr20_-_45985172 | 1.12 |
ENST00000536340.1
|
ZMYND8
|
zinc finger, MYND-type containing 8 |
| chr5_+_68788594 | 1.12 |
ENST00000396442.2
ENST00000380766.2 |
OCLN
|
occludin |
| chr1_-_155948218 | 1.11 |
ENST00000313667.4
|
ARHGEF2
|
Rho/Rac guanine nucleotide exchange factor (GEF) 2 |
| chr19_+_41860047 | 1.11 |
ENST00000604123.1
|
TMEM91
|
transmembrane protein 91 |
| chr13_-_45150392 | 1.10 |
ENST00000501704.2
|
TSC22D1
|
TSC22 domain family, member 1 |
| chr1_+_110754094 | 1.10 |
ENST00000369787.3
ENST00000413138.3 ENST00000438661.2 |
KCNC4
|
potassium voltage-gated channel, Shaw-related subfamily, member 4 |
| chr1_+_78470530 | 1.10 |
ENST00000370763.5
|
DNAJB4
|
DnaJ (Hsp40) homolog, subfamily B, member 4 |
| chr7_+_73442422 | 1.10 |
ENST00000358929.4
ENST00000431562.1 ENST00000320492.7 ENST00000438906.1 |
ELN
|
elastin |
| chr4_-_114682597 | 1.09 |
ENST00000394524.3
|
CAMK2D
|
calcium/calmodulin-dependent protein kinase II delta |
| chr6_+_30852130 | 1.08 |
ENST00000428153.2
ENST00000376568.3 ENST00000452441.1 ENST00000515219.1 |
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
| chr9_+_139971921 | 1.08 |
ENST00000409858.3
|
UAP1L1
|
UDP-N-acteylglucosamine pyrophosphorylase 1-like 1 |
| chr10_-_33623826 | 1.08 |
ENST00000374867.2
|
NRP1
|
neuropilin 1 |
| chr9_+_133971863 | 1.07 |
ENST00000372309.3
|
AIF1L
|
allograft inflammatory factor 1-like |
| chr1_+_87797351 | 1.07 |
ENST00000370542.1
|
LMO4
|
LIM domain only 4 |
| chr7_+_73442457 | 1.07 |
ENST00000438880.1
ENST00000414324.1 ENST00000380562.4 |
ELN
|
elastin |
| chr12_+_93965451 | 1.06 |
ENST00000548537.1
|
SOCS2
|
suppressor of cytokine signaling 2 |
| chr8_+_27491381 | 1.05 |
ENST00000337221.4
|
SCARA3
|
scavenger receptor class A, member 3 |
| chr7_-_86688940 | 1.05 |
ENST00000444627.1
|
KIAA1324L
|
KIAA1324-like |
| chr8_+_28747884 | 1.05 |
ENST00000287701.10
ENST00000444075.1 ENST00000403668.2 ENST00000519662.1 ENST00000558662.1 ENST00000523613.1 ENST00000560599.1 ENST00000397358.3 |
HMBOX1
|
homeobox containing 1 |
| chr10_+_35416223 | 1.03 |
ENST00000489321.1
ENST00000427847.2 ENST00000345491.3 ENST00000395895.2 ENST00000374728.3 ENST00000487132.1 |
CREM
|
cAMP responsive element modulator |
| chr18_+_46065483 | 1.03 |
ENST00000382998.4
|
CTIF
|
CBP80/20-dependent translation initiation factor |
| chr1_+_77747656 | 1.02 |
ENST00000354567.2
|
AK5
|
adenylate kinase 5 |
| chr9_+_71320557 | 1.02 |
ENST00000541509.1
|
PIP5K1B
|
phosphatidylinositol-4-phosphate 5-kinase, type I, beta |
| chr6_-_111804905 | 1.02 |
ENST00000358835.3
ENST00000435970.1 |
REV3L
|
REV3-like, polymerase (DNA directed), zeta, catalytic subunit |
| chr6_-_52860171 | 1.02 |
ENST00000370963.4
|
GSTA4
|
glutathione S-transferase alpha 4 |
| chr5_+_112849373 | 1.02 |
ENST00000161863.4
ENST00000515883.1 |
YTHDC2
|
YTH domain containing 2 |
| chr7_+_73442487 | 1.01 |
ENST00000380575.4
ENST00000380584.4 ENST00000458204.1 ENST00000357036.5 ENST00000417091.1 ENST00000429192.1 ENST00000442310.1 ENST00000380553.4 ENST00000380576.5 ENST00000428787.1 ENST00000320399.6 |
ELN
|
elastin |
| chr8_+_21912328 | 1.01 |
ENST00000432128.1
ENST00000443491.2 ENST00000517600.1 ENST00000523782.2 |
DMTN
|
dematin actin binding protein |
| chr19_+_34287751 | 1.01 |
ENST00000590771.1
ENST00000589786.1 ENST00000284006.6 ENST00000588881.1 |
KCTD15
|
potassium channel tetramerization domain containing 15 |
| chr8_+_28748099 | 1.01 |
ENST00000519047.1
|
HMBOX1
|
homeobox containing 1 |
| chr12_-_71003568 | 1.00 |
ENST00000547715.1
ENST00000451516.2 ENST00000538708.1 ENST00000550857.1 ENST00000261266.5 |
PTPRB
|
protein tyrosine phosphatase, receptor type, B |
| chr7_+_73442102 | 0.99 |
ENST00000445912.1
ENST00000252034.7 |
ELN
|
elastin |
| chr18_-_500692 | 0.97 |
ENST00000400256.3
|
COLEC12
|
collectin sub-family member 12 |
| chr17_+_35851570 | 0.97 |
ENST00000394386.1
|
DUSP14
|
dual specificity phosphatase 14 |
| chr14_-_100772862 | 0.97 |
ENST00000359232.3
|
SLC25A29
|
solute carrier family 25 (mitochondrial carnitine/acylcarnitine carrier), member 29 |
| chr14_-_100772767 | 0.96 |
ENST00000392908.3
ENST00000539621.1 |
SLC25A29
|
solute carrier family 25 (mitochondrial carnitine/acylcarnitine carrier), member 29 |
| chr5_-_111093081 | 0.96 |
ENST00000453526.2
ENST00000509427.1 |
NREP
|
neuronal regeneration related protein |
| chr11_+_33563821 | 0.95 |
ENST00000321505.4
ENST00000265654.5 ENST00000389726.3 |
KIAA1549L
|
KIAA1549-like |
| chr10_-_33623564 | 0.95 |
ENST00000374875.1
ENST00000374822.4 |
NRP1
|
neuropilin 1 |
| chr3_-_141747459 | 0.95 |
ENST00000477292.1
ENST00000478006.1 ENST00000495310.1 ENST00000486111.1 |
TFDP2
|
transcription factor Dp-2 (E2F dimerization partner 2) |
| chr14_-_21270995 | 0.94 |
ENST00000555698.1
ENST00000397970.4 ENST00000340900.3 |
RNASE1
|
ribonuclease, RNase A family, 1 (pancreatic) |
| chr18_-_72920372 | 0.94 |
ENST00000581620.1
ENST00000582437.1 |
ZADH2
|
zinc binding alcohol dehydrogenase domain containing 2 |
| chr20_-_45985464 | 0.94 |
ENST00000458360.2
ENST00000262975.4 |
ZMYND8
|
zinc finger, MYND-type containing 8 |
| chr1_-_20812690 | 0.93 |
ENST00000375078.3
|
CAMK2N1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
| chr14_-_76127519 | 0.93 |
ENST00000256319.6
|
C14orf1
|
chromosome 14 open reading frame 1 |
| chr9_-_100459639 | 0.93 |
ENST00000375128.4
|
XPA
|
xeroderma pigmentosum, complementation group A |
| chr3_+_43328004 | 0.93 |
ENST00000454177.1
ENST00000429705.2 ENST00000296088.7 ENST00000437827.1 |
SNRK
|
SNF related kinase |
| chr10_-_103874692 | 0.92 |
ENST00000361198.5
|
LDB1
|
LIM domain binding 1 |
| chr13_-_110438914 | 0.92 |
ENST00000375856.3
|
IRS2
|
insulin receptor substrate 2 |
| chrX_+_100333709 | 0.92 |
ENST00000372930.4
|
TMEM35
|
transmembrane protein 35 |
| chr2_-_191878874 | 0.91 |
ENST00000392322.3
ENST00000392323.2 ENST00000424722.1 ENST00000361099.3 |
STAT1
|
signal transducer and activator of transcription 1, 91kDa |
| chr13_-_101327028 | 0.90 |
ENST00000328767.5
ENST00000342624.5 ENST00000376234.3 ENST00000423847.1 |
TMTC4
|
transmembrane and tetratricopeptide repeat containing 4 |
| chr20_-_45985414 | 0.90 |
ENST00000461685.1
ENST00000372023.3 ENST00000540497.1 ENST00000435836.1 ENST00000471951.2 ENST00000352431.2 ENST00000396281.4 ENST00000355972.4 ENST00000360911.3 |
ZMYND8
|
zinc finger, MYND-type containing 8 |
| chr14_-_89883412 | 0.90 |
ENST00000557258.1
|
FOXN3
|
forkhead box N3 |
| chr12_+_48513009 | 0.89 |
ENST00000359794.5
ENST00000551339.1 ENST00000395233.2 ENST00000548345.1 |
PFKM
|
phosphofructokinase, muscle |
| chr4_-_90756769 | 0.89 |
ENST00000345009.4
ENST00000505199.1 ENST00000502987.1 |
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor) |
| chr9_-_124991124 | 0.88 |
ENST00000394319.4
ENST00000340587.3 |
LHX6
|
LIM homeobox 6 |
| chr12_+_3186521 | 0.88 |
ENST00000537971.1
ENST00000011898.5 |
TSPAN9
|
tetraspanin 9 |
| chr10_+_119301928 | 0.88 |
ENST00000553456.3
|
EMX2
|
empty spiracles homeobox 2 |
| chr1_+_109656532 | 0.87 |
ENST00000531664.1
ENST00000534476.1 |
KIAA1324
|
KIAA1324 |
| chr9_-_15510989 | 0.87 |
ENST00000380715.1
ENST00000380716.4 ENST00000380738.4 ENST00000380733.4 |
PSIP1
|
PC4 and SFRS1 interacting protein 1 |
| chr5_-_141257954 | 0.87 |
ENST00000456271.1
ENST00000394536.3 ENST00000503492.1 ENST00000287008.3 |
PCDH1
|
protocadherin 1 |
| chr5_+_61708582 | 0.85 |
ENST00000325324.6
|
IPO11
|
importin 11 |
| chr10_+_35484053 | 0.85 |
ENST00000487763.1
ENST00000473940.1 ENST00000488328.1 ENST00000356917.5 |
CREM
|
cAMP responsive element modulator |
| chr1_-_110933663 | 0.84 |
ENST00000369781.4
ENST00000541986.1 ENST00000369779.4 |
SLC16A4
|
solute carrier family 16, member 4 |
| chr9_-_5833027 | 0.82 |
ENST00000339450.5
|
ERMP1
|
endoplasmic reticulum metallopeptidase 1 |
| chrX_-_70474377 | 0.82 |
ENST00000373978.1
ENST00000373981.1 |
ZMYM3
|
zinc finger, MYM-type 3 |
| chr12_+_48513570 | 0.82 |
ENST00000551804.1
|
PFKM
|
phosphofructokinase, muscle |
| chr12_+_56915776 | 0.82 |
ENST00000550726.1
ENST00000542360.1 |
RBMS2
|
RNA binding motif, single stranded interacting protein 2 |
| chrX_+_109245863 | 0.82 |
ENST00000372072.3
|
TMEM164
|
transmembrane protein 164 |
| chr1_+_156561533 | 0.81 |
ENST00000368234.3
ENST00000368235.3 ENST00000368233.3 |
APOA1BP
|
apolipoprotein A-I binding protein |
| chr1_-_110933611 | 0.81 |
ENST00000472422.2
ENST00000437429.2 |
SLC16A4
|
solute carrier family 16, member 4 |
| chr2_+_8822113 | 0.79 |
ENST00000396290.1
ENST00000331129.3 |
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein |
| chr5_+_36876833 | 0.79 |
ENST00000282516.8
ENST00000448238.2 |
NIPBL
|
Nipped-B homolog (Drosophila) |
| chr11_+_7506713 | 0.79 |
ENST00000329293.3
ENST00000534244.1 |
OLFML1
|
olfactomedin-like 1 |
| chr17_-_19771242 | 0.79 |
ENST00000361658.2
|
ULK2
|
unc-51 like autophagy activating kinase 2 |
| chr7_-_100808843 | 0.78 |
ENST00000249330.2
|
VGF
|
VGF nerve growth factor inducible |
| chrX_+_73641286 | 0.77 |
ENST00000587091.1
|
SLC16A2
|
solute carrier family 16, member 2 (thyroid hormone transporter) |
| chr15_-_64995399 | 0.77 |
ENST00000559753.1
ENST00000560258.2 ENST00000559912.2 ENST00000326005.6 |
OAZ2
|
ornithine decarboxylase antizyme 2 |
| chr3_+_141105235 | 0.77 |
ENST00000503809.1
|
ZBTB38
|
zinc finger and BTB domain containing 38 |
| chr5_-_107006596 | 0.77 |
ENST00000333274.6
|
EFNA5
|
ephrin-A5 |
Network of associatons between targets according to the STRING database.
First level regulatory network of GTF2I
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.7 | 5.1 | GO:2000006 | apoptotic process involved in endocardial cushion morphogenesis(GO:0003277) intermediate mesoderm morphogenesis(GO:0048390) intermediate mesoderm formation(GO:0048391) intermediate mesodermal cell differentiation(GO:0048392) regulation of cardiac muscle fiber development(GO:0055018) positive regulation of cardiac muscle fiber development(GO:0055020) bud dilation involved in lung branching(GO:0060503) BMP signaling pathway involved in ureter morphogenesis(GO:0061149) renal system segmentation(GO:0061150) BMP signaling pathway involved in renal system segmentation(GO:0061151) pulmonary artery endothelial tube morphogenesis(GO:0061155) regulation of transcription from RNA polymerase II promoter involved in mesonephros development(GO:0061216) BMP signaling pathway involved in nephric duct formation(GO:0071893) negative regulation of branch elongation involved in ureteric bud branching(GO:0072096) negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway(GO:0072097) anterior/posterior pattern specification involved in ureteric bud development(GO:0072099) specification of ureteric bud anterior/posterior symmetry(GO:0072100) specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway(GO:0072101) ureter epithelial cell differentiation(GO:0072192) negative regulation of mesenchymal cell proliferation involved in ureter development(GO:0072200) positive regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901964) cardiac jelly development(GO:1905072) regulation of metanephric S-shaped body morphogenesis(GO:2000004) negative regulation of metanephric S-shaped body morphogenesis(GO:2000005) regulation of metanephric comma-shaped body morphogenesis(GO:2000006) negative regulation of metanephric comma-shaped body morphogenesis(GO:2000007) |
| 1.4 | 4.1 | GO:0072229 | carbon dioxide transmembrane transport(GO:0035378) proximal convoluted tubule development(GO:0072019) metanephric proximal convoluted tubule development(GO:0072229) |
| 1.2 | 39.0 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
| 1.2 | 8.3 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 1.1 | 5.3 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
| 1.0 | 4.2 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
| 1.0 | 3.0 | GO:2000830 | vacuolar phosphate transport(GO:0007037) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
| 1.0 | 2.9 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
| 0.9 | 3.7 | GO:0072308 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) |
| 0.8 | 2.4 | GO:0021793 | chemorepulsion of branchiomotor axon(GO:0021793) |
| 0.8 | 3.1 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
| 0.6 | 1.9 | GO:0015817 | acyl carnitine transport(GO:0006844) histidine transport(GO:0015817) L-histidine transmembrane transport(GO:0089709) L-histidine transport(GO:1902024) acyl carnitine transmembrane transport(GO:1902616) |
| 0.6 | 2.9 | GO:1905040 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
| 0.6 | 1.7 | GO:0093001 | glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
| 0.5 | 3.0 | GO:1903756 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 0.5 | 1.9 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.5 | 1.8 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
| 0.5 | 1.4 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.4 | 1.3 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 0.4 | 1.5 | GO:0044467 | glial cell-derived neurotrophic factor secretion(GO:0044467) regulation of glial cell-derived neurotrophic factor secretion(GO:1900166) positive regulation of glial cell-derived neurotrophic factor secretion(GO:1900168) |
| 0.3 | 1.3 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.3 | 1.3 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.3 | 1.0 | GO:0098582 | innate vocalization behavior(GO:0098582) |
| 0.3 | 1.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
| 0.3 | 0.5 | GO:0001300 | chronological cell aging(GO:0001300) |
| 0.3 | 1.3 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.3 | 0.8 | GO:0061010 | gall bladder development(GO:0061010) |
| 0.3 | 1.0 | GO:0009183 | ADP biosynthetic process(GO:0006172) purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
| 0.3 | 2.5 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.2 | 1.5 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.2 | 1.0 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
| 0.2 | 1.9 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.2 | 1.6 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.2 | 2.5 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.2 | 0.7 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.2 | 0.7 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.2 | 1.3 | GO:1901909 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.2 | 1.3 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.2 | 0.8 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 0.2 | 0.6 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.2 | 0.6 | GO:0010652 | pulmonary valve formation(GO:0003193) regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) foramen ovale closure(GO:0035922) regulation of AV node cell action potential(GO:0098904) regulation of bundle of His cell action potential(GO:0098905) |
| 0.2 | 1.6 | GO:0075071 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.2 | 0.8 | GO:1902723 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.2 | 1.2 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.2 | 0.6 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
| 0.2 | 0.4 | GO:0021650 | vestibulocochlear nerve morphogenesis(GO:0021648) vestibulocochlear nerve formation(GO:0021650) |
| 0.2 | 1.5 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
| 0.2 | 0.9 | GO:0006696 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
| 0.2 | 0.7 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) |
| 0.2 | 1.3 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.2 | 2.3 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
| 0.2 | 0.9 | GO:1903285 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
| 0.2 | 0.5 | GO:0098759 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) interleukin-1 beta biosynthetic process(GO:0050720) response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
| 0.2 | 0.7 | GO:1904450 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 0.2 | 1.0 | GO:0070560 | protein secretion by platelet(GO:0070560) |
| 0.2 | 0.8 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
| 0.2 | 1.6 | GO:0034350 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
| 0.2 | 0.5 | GO:0032765 | positive regulation of mast cell cytokine production(GO:0032765) |
| 0.2 | 0.6 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
| 0.2 | 0.8 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 0.2 | 0.5 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
| 0.2 | 0.9 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 0.2 | 0.6 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
| 0.2 | 1.9 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
| 0.2 | 0.8 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.2 | 0.6 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.2 | 2.0 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
| 0.1 | 0.4 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
| 0.1 | 1.6 | GO:0014894 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.1 | 0.9 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
| 0.1 | 0.4 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 0.1 | 1.1 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.1 | 0.7 | GO:0010748 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
| 0.1 | 4.0 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.1 | 0.7 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 0.1 | 0.7 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
| 0.1 | 1.5 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
| 0.1 | 0.7 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
| 0.1 | 0.8 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.1 | 0.5 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
| 0.1 | 0.8 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.1 | 0.6 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.1 | 0.9 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 0.1 | 0.2 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.1 | 0.4 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 0.1 | 2.5 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
| 0.1 | 1.3 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.1 | 1.1 | GO:0060591 | chondroblast differentiation(GO:0060591) |
| 0.1 | 0.6 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
| 0.1 | 0.1 | GO:0010159 | specification of organ position(GO:0010159) |
| 0.1 | 0.5 | GO:2000721 | pilomotor reflex(GO:0097195) positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
| 0.1 | 2.5 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
| 0.1 | 0.9 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.1 | 0.3 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
| 0.1 | 0.4 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 0.1 | 0.3 | GO:0051780 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
| 0.1 | 0.9 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
| 0.1 | 0.3 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 0.1 | 0.4 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 0.1 | 1.6 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
| 0.1 | 0.3 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
| 0.1 | 2.0 | GO:0021930 | cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
| 0.1 | 0.4 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
| 0.1 | 1.1 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
| 0.1 | 0.9 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.1 | 2.0 | GO:0009650 | UV protection(GO:0009650) |
| 0.1 | 0.1 | GO:0006267 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.1 | 0.4 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.1 | 0.5 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 0.1 | 0.4 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 | 0.4 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
| 0.1 | 0.8 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
| 0.1 | 2.1 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
| 0.1 | 0.4 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.1 | 0.3 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
| 0.1 | 0.3 | GO:0051030 | snRNA transport(GO:0051030) |
| 0.1 | 2.4 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
| 0.1 | 0.8 | GO:0032057 | negative regulation of translational initiation in response to stress(GO:0032057) |
| 0.1 | 1.8 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.1 | 0.5 | GO:0070836 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) |
| 0.1 | 0.7 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.1 | 8.7 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
| 0.1 | 0.3 | GO:0061188 | negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.1 | 0.9 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 0.1 | 1.1 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.1 | 0.4 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
| 0.1 | 1.0 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
| 0.1 | 0.2 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
| 0.1 | 0.2 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 0.1 | 2.3 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
| 0.1 | 0.7 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.1 | 0.2 | GO:0002194 | hepatocyte cell migration(GO:0002194) otic placode formation(GO:0043049) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
| 0.1 | 2.2 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
| 0.1 | 1.2 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
| 0.1 | 0.2 | GO:0009405 | pathogenesis(GO:0009405) |
| 0.1 | 0.4 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
| 0.1 | 0.1 | GO:0021539 | subthalamus development(GO:0021539) |
| 0.1 | 0.4 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.1 | 3.6 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
| 0.1 | 0.1 | GO:0060431 | primary lung bud formation(GO:0060431) |
| 0.1 | 0.7 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
| 0.1 | 0.7 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
| 0.1 | 0.4 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
| 0.1 | 0.4 | GO:0014004 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.1 | 0.7 | GO:0001955 | blood vessel maturation(GO:0001955) |
| 0.1 | 0.6 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.1 | 0.4 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
| 0.1 | 0.3 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.1 | 0.2 | GO:0003064 | regulation of heart rate by hormone(GO:0003064) |
| 0.1 | 0.3 | GO:0048749 | compound eye development(GO:0048749) |
| 0.1 | 0.9 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.1 | 7.7 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
| 0.1 | 0.7 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.1 | 0.2 | GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
| 0.1 | 0.3 | GO:0060168 | positive regulation of adenosine receptor signaling pathway(GO:0060168) |
| 0.1 | 1.3 | GO:0006293 | nucleotide-excision repair, preincision complex stabilization(GO:0006293) |
| 0.1 | 0.8 | GO:2000582 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.1 | 0.5 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.1 | 0.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.1 | 0.1 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.1 | 0.1 | GO:0021897 | forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) |
| 0.1 | 1.7 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.1 | 0.1 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.1 | 1.4 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.1 | 0.8 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.1 | 0.4 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.1 | 0.1 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
| 0.1 | 0.2 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
| 0.1 | 1.3 | GO:0006012 | galactose metabolic process(GO:0006012) |
| 0.1 | 0.7 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.1 | 0.1 | GO:0055095 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
| 0.1 | 1.8 | GO:0060074 | synapse maturation(GO:0060074) |
| 0.1 | 0.2 | GO:0032072 | plasmacytoid dendritic cell activation(GO:0002270) T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) regulation of restriction endodeoxyribonuclease activity(GO:0032072) |
| 0.1 | 0.3 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
| 0.1 | 0.5 | GO:0042426 | choline catabolic process(GO:0042426) |
| 0.1 | 0.3 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 0.1 | 0.2 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
| 0.1 | 0.2 | GO:0035905 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
| 0.1 | 0.3 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 0.1 | 0.6 | GO:0070206 | protein trimerization(GO:0070206) |
| 0.0 | 0.3 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 0.0 | 0.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 0.0 | 0.2 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.0 | 1.4 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
| 0.0 | 0.4 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
| 0.0 | 0.5 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.0 | 0.0 | GO:0071338 | submandibular salivary gland formation(GO:0060661) hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) positive regulation of hair follicle cell proliferation(GO:0071338) |
| 0.0 | 1.2 | GO:0002021 | response to dietary excess(GO:0002021) |
| 0.0 | 0.5 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.0 | 0.5 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.0 | 0.5 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.0 | 0.6 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 0.0 | 0.3 | GO:0044334 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.0 | 0.2 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
| 0.0 | 0.3 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
| 0.0 | 0.5 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.0 | 0.2 | GO:1990523 | bone regeneration(GO:1990523) |
| 0.0 | 0.2 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.0 | 0.3 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.0 | 1.8 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.0 | 0.4 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
| 0.0 | 0.4 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
| 0.0 | 0.2 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.0 | 1.4 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.0 | 0.1 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
| 0.0 | 0.1 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.0 | 0.5 | GO:0039529 | RIG-I signaling pathway(GO:0039529) |
| 0.0 | 0.2 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
| 0.0 | 0.3 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.0 | 0.2 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
| 0.0 | 0.3 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 0.0 | 0.4 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.0 | 0.3 | GO:1902856 | negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 0.0 | 0.1 | GO:0072553 | terminal button organization(GO:0072553) |
| 0.0 | 0.3 | GO:0070885 | positive regulation of sodium:proton antiporter activity(GO:0032417) negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.0 | 0.1 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
| 0.0 | 0.2 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
| 0.0 | 0.1 | GO:0034445 | regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
| 0.0 | 0.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.0 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
| 0.0 | 0.6 | GO:0097320 | membrane tubulation(GO:0097320) |
| 0.0 | 0.6 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
| 0.0 | 0.5 | GO:0060004 | reflex(GO:0060004) |
| 0.0 | 0.5 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.0 | 1.4 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 0.0 | 1.7 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.0 | 0.2 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.0 | 0.2 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.0 | 1.0 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.0 | 0.6 | GO:0006853 | carnitine shuttle(GO:0006853) |
| 0.0 | 1.5 | GO:0007019 | microtubule depolymerization(GO:0007019) |
| 0.0 | 0.4 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
| 0.0 | 0.5 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 0.0 | 0.4 | GO:0010226 | response to lithium ion(GO:0010226) |
| 0.0 | 0.1 | GO:0007538 | primary sex determination(GO:0007538) |
| 0.0 | 0.3 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.0 | 0.5 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
| 0.0 | 0.3 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.0 | 0.5 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
| 0.0 | 0.5 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
| 0.0 | 0.3 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
| 0.0 | 0.2 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
| 0.0 | 0.3 | GO:0032049 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin biosynthetic process(GO:0032049) |
| 0.0 | 0.2 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 0.0 | 0.4 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
| 0.0 | 0.1 | GO:2000301 | response to antineoplastic agent(GO:0097327) negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.0 | 0.1 | GO:0051383 | kinetochore organization(GO:0051383) |
| 0.0 | 0.7 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.0 | 0.2 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.0 | 0.4 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.0 | 0.1 | GO:0045991 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) carbon catabolite activation of transcription(GO:0045991) positive regulation of transcription by glucose(GO:0046016) |
| 0.0 | 0.3 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) |
| 0.0 | 0.2 | GO:0048733 | sebaceous gland development(GO:0048733) |
| 0.0 | 0.6 | GO:0001502 | cartilage condensation(GO:0001502) |
| 0.0 | 1.1 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.0 | 0.2 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
| 0.0 | 0.1 | GO:0033292 | T-tubule organization(GO:0033292) protein localization to T-tubule(GO:0036371) regulation of SA node cell action potential(GO:0098907) |
| 0.0 | 0.4 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.0 | 0.2 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
| 0.0 | 0.8 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
| 0.0 | 0.1 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
| 0.0 | 0.6 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.0 | 0.2 | GO:0050872 | white fat cell differentiation(GO:0050872) |
| 0.0 | 1.0 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.0 | 2.1 | GO:0006446 | regulation of translational initiation(GO:0006446) |
| 0.0 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.0 | 1.7 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
| 0.0 | 0.3 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.0 | 0.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.0 | 1.2 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.0 | 0.5 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
| 0.0 | 1.0 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
| 0.0 | 0.7 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.0 | 0.0 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
| 0.0 | 0.6 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.0 | 0.2 | GO:0034036 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.0 | 0.3 | GO:0000050 | urea cycle(GO:0000050) |
| 0.0 | 0.6 | GO:0070207 | protein homotrimerization(GO:0070207) |
| 0.0 | 3.1 | GO:0006334 | nucleosome assembly(GO:0006334) |
| 0.0 | 0.6 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.0 | 2.4 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
| 0.0 | 0.2 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.0 | 0.2 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.0 | 0.3 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.0 | 1.6 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.0 | 1.2 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
| 0.0 | 0.7 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
| 0.0 | 0.1 | GO:0031017 | exocrine pancreas development(GO:0031017) |
| 0.0 | 0.1 | GO:0002501 | peptide antigen assembly with MHC protein complex(GO:0002501) peptide antigen assembly with MHC class II protein complex(GO:0002503) |
| 0.0 | 0.1 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) negative regulation of histone H3-K4 methylation(GO:0051572) |
| 0.0 | 0.1 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.0 | 0.1 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.0 | 0.4 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.0 | 0.3 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.0 | 0.4 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.0 | 0.2 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.0 | 0.2 | GO:0090179 | regulation of establishment of planar polarity involved in neural tube closure(GO:0090178) planar cell polarity pathway involved in neural tube closure(GO:0090179) |
| 0.0 | 0.1 | GO:0050917 | sensory perception of sweet taste(GO:0050916) sensory perception of umami taste(GO:0050917) |
| 0.0 | 0.3 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.0 | 0.9 | GO:0035329 | hippo signaling(GO:0035329) |
| 0.0 | 0.1 | GO:0046373 | arabinose metabolic process(GO:0019566) L-arabinose metabolic process(GO:0046373) |
| 0.0 | 0.4 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.0 | 0.0 | GO:0032493 | response to bacterial lipoprotein(GO:0032493) detection of bacterial lipoprotein(GO:0042494) |
| 0.0 | 0.1 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.0 | 0.0 | GO:1903553 | myoblast development(GO:0048627) positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.0 | 0.2 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
| 0.0 | 0.3 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.0 | 0.5 | GO:1903170 | negative regulation of calcium ion transmembrane transport(GO:1903170) |
| 0.0 | 0.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
| 0.0 | 0.4 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.0 | 0.2 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.0 | 0.1 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
| 0.0 | 0.3 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
| 0.0 | 0.3 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
| 0.0 | 0.6 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
| 0.0 | 0.2 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
| 0.0 | 0.2 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
| 0.0 | 0.1 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.0 | 0.2 | GO:0010225 | response to UV-C(GO:0010225) |
| 0.0 | 0.4 | GO:0021591 | ventricular system development(GO:0021591) |
| 0.0 | 0.1 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
| 0.0 | 0.1 | GO:0002159 | desmosome assembly(GO:0002159) |
| 0.0 | 0.1 | GO:0044320 | cellular response to leptin stimulus(GO:0044320) |
| 0.0 | 0.1 | GO:1990910 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) response to hypobaric hypoxia(GO:1990910) |
| 0.0 | 0.1 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
| 0.0 | 0.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.0 | 0.6 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.0 | 0.0 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
| 0.0 | 0.0 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
| 0.0 | 0.3 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
| 0.0 | 0.0 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.0 | 0.0 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.0 | 0.1 | GO:0032225 | regulation of synaptic transmission, dopaminergic(GO:0032225) |
| 0.0 | 0.2 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
| 0.0 | 0.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.0 | 1.0 | GO:0007588 | excretion(GO:0007588) |
| 0.0 | 0.2 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
| 0.0 | 0.4 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
| 0.0 | 0.4 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
| 0.0 | 0.3 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
| 0.0 | 0.3 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
| 0.0 | 0.1 |